SUBSCRIBE

Australia reviewing plans for naming biosimilars

 posted 23/01/2015

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), has changed its plans for naming biosimilars, ‘following recent international...

more
Biosimilar etanercept submitted for approval in EU Biosimilars/News | Posted 23/01/2015
Generics applications under review by EMA – Dec... Generics/General | Posted 23/01/2015
Filgrastim biosimilar has similar safety and ef... Biosimilars/Research | Posted 23/01/2015
Amgen’s approach in the biosimilars market Pharma News | Posted 23/01/2015
Prasco to market authorized colchicine generic... Generics/News | Posted 23/01/2015
UK outlines process for developing biosimilars... Policies & Legislation | Posted 23/01/2015
Mabion starts phase III trial for rituximab bio... Biosimilars/News | Posted 23/01/2015
Top 10 most read GaBI Online articles in 2014 Pharma News | Posted 16/01/2015
Patient perceptions of generics in Ireland Generics/Research | Posted 16/01/2015
Hospira submits application to FDA for epoetin... Biosimilars/News | Posted 16/01/2015
Biocomparable has comparable safety and efficac... Biosimilars/Research | Posted 16/01/2015
Apotex pegfilgrastim biosimilar under FDA review Biosimilars/News | Posted 16/01/2015
EMA issues revised guideline on clinical and no... Guidelines | Posted 16/01/2015
US judge invalidates 4 of 5 patents on Cubicin Generics/News | Posted 16/01/2015
Compromise reached on US legislation on biosimi... Policies & Legislation | Posted 16/01/2015
Biosimilars 2015 Conferences | Posted 16/01/2015
Extrapolation of indications in biosimilars: in... Biosimilars/Research | Posted 09/01/2015
FDA advisers recommend approval of filgrastim b... Biosimilars/News | Posted 09/01/2015
EU problematic patent settlements stabilize Reports | Posted 09/01/2015
First infliximab ‘similar biologic’ launched in... Biosimilars/News | Posted 09/01/2015
GPhA comments on generics’ legislation and Tran... Generics/General | Posted 09/01/2015
Phase I study shows darbepoetin alfa biosimilar... Biosimilars/Research | Posted 09/01/2015
Generics makers to be penalized for huge price... Policies & Legislation | Posted 09/01/2015
Biosimilars could save US$44.2 billion over 10... Reports | Posted 09/01/2015
Extrapolation of indications in biosimilars: ep... Biosimilars/Research | Posted 12/12/2014
Canada’s generics are too expensive Generics/Research | Posted 12/12/2014
Non-biological complex drug concept: experience... Biosimilars/Research | Posted 12/12/2014
Trade groups comment on China’s biosimilars gui... Policies & Legislation | Posted 12/12/2014
EU Member States suspend generics approvals due... Generics/General | Posted 12/12/2014
Momenta gains approval to start biosimilar adal... Biosimilars/News | Posted 12/12/2014
UK uses less brand-name medicines per person Reports | Posted 12/12/2014
First celecoxib generics hit US market Generics/News | Posted 12/12/2014
EBG–Biosimilars 2015 Conferences | Posted 12/12/2014
US biosimilar uptake in the light of Obamacare Biosimilars/Research | Posted 05/12/2014
Irish pharmacists’ perceptions and attitudes to... Generics/Research | Posted 05/12/2014
Biosimilar infliximab launched in Japan Biosimilars/News | Posted 05/12/2014
Use of biosimilars in rheumatology Biosimilars/Research | Posted 05/12/2014
Cipla makes deal with Serum Institute for vacci... Pharma News | Posted 05/12/2014
Generics makers challenging more patents Reports | Posted 05/12/2014
Stada to in-license adalimumab biosimilar Biosimilars/News | Posted 05/12/2014
FDA delays finalization of generics labelling rule Policies & Legislation | Posted 05/12/2014
Comparison of biosimilar filgrastim versus othe... Biosimilars/Research | Posted 28/11/2014
EuropaBio calls for distinguishable names for b... Biosimilars/General | Posted 28/11/2014
Generics losing out to brand-name drugs in Croatia Generics/Research | Posted 28/11/2014
FDA to carry out survey into affect of generics... Guidelines | Posted 28/11/2014
Developments in the US over state biosimilars s... Policies & Legislation | Posted 28/11/2014
FDA withdraws automatic substitution of two met... Generics/News | Posted 28/11/2014
Amgen expands biosimilars programme Biosimilars/News | Posted 28/11/2014
Actavis buys Allergan and joins pharma top 10 Pharma News | Posted 28/11/2014
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections